Introduction: Eighth Banff Conference on Allograft Pathology - Edmonton, AB Kim Solez, M.D. and Lorraine C. Racusen.

Slides:



Advertisements
Similar presentations
CD10, scored as positive versus negative all path 1 path 2 path 3 path 4 path 5 path 6 path 7 path 8 path 9 CD10 can be reproducibly scored, but is very.
Advertisements

Significance of the total i-score
Chronic vascular injury of the kidney allograft: The contribution of rejection Heinz Regele Heinz Regele Department of Pathology Innsbruck Medical University.
Michael Mengel Department of Laboratory Medicine and Pathology
Tuesday Case Conference May Biopsy finding LM –Glomeruli are normal in size to mildly enlarged Mild enlargement of the mesangial areas with occasional.
Kidney allografts with biopsy features of chronic mixed rejection reflect poorer survival than those with pure chronic antibody-mediated rejection D. Dobi,
The Value of Zero-Hour Implantation Biopsies Volker Nickeleit Nephropathology Laboratory, Department of Pathology The University of North Carolina, Chapel.
Preimplantation analysis of kidney biopsies from expanded criteria donors Amaia Sagasta, Ana Sánchez-Escuredo, Frederic Oppenheimer, Manel Solé Department.
PATHOLOGIC DIAGNOSIS OF ANTIBODY-MEDIATED REJECTION (AMR) Histopathologic findings Immunopathologic findings Immunohistochemistry on paraffin sections.
POLYOMAVIRUS INFECTION IN RENAL ALLOGRAFTS: PROGRESS SINCE BANFF 1999 Parmjeet Randhawa Associate Professor Division of Transplantation Pathology Department.
The value of protocol biopsies in renal allografts Gordana Petrusevska Skopje, Macedonia Gordana Petrusevska Skopje, Macedonia.
The Significance of C4d Staining with Minimal Histologic Abnormalities
BANFF SCHEMA FOR GRADING PANCREAS ALLOGRAFT REJECTION
Slide 1PUBLICATIONS Racusen/Solez meeting report for AJT. Racusen/Solez meeting report for AJT. Manuscript on antibody-mediated rejection. Manuscript on.
Pancreas Transplant Pathology: Controversial Lesions Lois J. Arend PhD, MD University of Cincinnati Department of Pathology.
Six years since the Banff Clinical Practice Guidelines: Practical reality comes crashing down on the pure thinking of Banff 1999 L. G. Hunsicker, M.D.
Standardization in Renal Allograft Biopsy Interpretation: The Banff Classification Kim Solez, M.D.
Sum Scores & Components’ Scores Chronic Scores Acute Rejection Scores Lillian W. Gaber University of Tennessee.
Calcineurin Inhibitor Toxicity In Kidney Allograft Protocol Biopsies Neeraja Kambham M.D. Stanford University.
Journal Reading Present by Dr. 陳志榮. The Banff 97 Working Classification of Renal Allograft Pathology Racusen LC, Solez K, Colvin RB, Bonsib.
The Banff Classification: Slide Seminar Kim Solez, M.D.
Donor Organ Selection Criteria: What is Ideal? A Consensus (?) Discussion.
GRADING OF REJECTION IN PANCREAS ALLOGRAFTS Are changes needed? Cinthia B. Drachenberg, M.D. University of Maryland School of Medicine Baltimore MD.
Introduction: On Banff 2003, Aberdeen, Scotland, and What Robert Burns Would Think! Kim Solez, M.D.
Schemas for Histopathological Diagnosis of Rejection: Kidney Schemas for Histopathological Diagnosis of Rejection: Kidney Kim Solez, M.D.
Summaries by Session Chairs of Banff 2003: C4d scoring/Ab mediated reject. - Bob Colvin GeneAnalysis/Microarrays/Tubulitis/Tolerance - Lorraine Racusen.
The European experience with protocol biopsies Ian Roberts Oxford, UK Oxford Pathology.
MONOCYTE/MACROPHAGES AND C4d IN RENAL ALLOGRAFTS Alex Magil, MD.
Sum Scores and Scores of Individual Components in Clinical Practice and Clinical Trials Lillian W. Gaber University of Tennessee.
Draft guideline for scoring and reporting interstitial fibrosis Working Group on Fibrosis Banff 09 Colvin RB Banff 2009.
Looking Back: Reflections on Banff 1991 From Banff 2003 Douglas R. Wilson, M.D.
C4d - staining: Comparison of methods C. Seemayer, A. Gaspert, M. Mihatsch.
Welcome and Introduction to the Tenth Banff Conference on Allograft Pathology Kim Solez, M.D. Lorraine Racusen, M.D.
Marc Halushka MD, PhD Johns Hopkins University SOM 10 th Banff Conference on Allograft Pathology August 12, 2009.
Agnieszka Perkowska-Ptasinska1, M. Ciszek, A.L. Urbanowicz, L. Paczek,
A year after the conception of the Technology and Future of Medicine Course (LABMP 590) it is useful to reflect on its progress and evolution.
Section 3 Transplant Rejection
Pathology of Kidney and the Urinary tract
Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.
Reproducibility for C4d immunohistochemistry in renal allografts – results from the Banff Trial Banff Initiative for Quality Assurance in Transplantation.
Severe vascular lesions and poor functional outcome
Polyomavirus nephropathy: updated Helmut Hopfer, Basel, Switzerland.
Kidney transplant case Niels Marcussen Hans Dieperink Odense University Hospital.
Humoral rejection: What the pathologist needs to know Humoral rejection: What the pathologist needs to know Heinz Regele Heinz Regele Clinical Institute.
Sulen Sarioglu, Mehtat Unlu, Mustafa Sakar, Taner Camsari, Mehmet Turkmen, Hulya Ellidokuz Departments of Pathology, Biomedical Technology, Nephrology,
Pathology of Kidney and the Urinary tract Dr. Amar C. Al-Rikabi Dr. Hala Kasouf Kfouri.
Prognostic significance of C4-positive vs. negative rejection Heinz Regele Heinz Regele Department of Pathology Innsbruck Medical University Heinz Regele.
UK National Renal Transplant EQA Scheme Ian Roberts Department of Cellular Pathology, Oxford Radcliffe Hospitals The National Renal Transplant EQA Scheme.
C4d in pancreas transplant biopsies: the Leiden experience Ingeborg Bajema Ingeborg Bajema Ingeborg Bajema.
Histological markers of CNI nephrotoxicity: Specific or not specific? Marion Rabant MD, Renaud Snanoudj MD, Virginie Royal MD, C. Girardin, E.Morelon MD.
U # Cad Tx 15 years ago Recent  creatinine with mild proteinuria No RAS.
U # Chronic renal failure – secondary to IgA nephropathy. Deceased donor kidney transplant – August Complicated by delayed graft.
Pathology of Renal Transplantation
Acute rejection after kidney transplantation
The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant Apr;9(4):812-9.
U # LRD kid tx March/99 Original Dis IgA.
ACTIVATION OF MITOCHONDRIAL APOPTOTIC PATHWAY IN CADAVER KIDNEY
Smooth muscle–specific actin levels in the urine of renal transplant recipients: Correlation with cyclosporine or tacrolimus nephrotoxicity  Mark Haas,
Mechanism and Treatment of Antibody-Mediated Rejection
Enterprise | Interest Nothing to disclose.
Anand Yuvaraj International Transplant Fellow
Volume 77, Issue 9, Pages (May 2010)
T. N. Nikonenko, A. V. Trailin and A. S. Nikonenko
Histomorphology in a case of mixed (cellular and humoral) acute kidney allograft rejection (patient 10). Histomorphology in a case of mixed (cellular and.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Volume 80, Issue 12, Pages (December 2011)
Volume 67, Issue 1, Pages (January 2005)
The Banff classification revisited
Post-transplant membranous glomerulonephritis as a manifestation of chronic antibody-mediated rejection Hyeon Joo Jeong, Beom Jin Lim, Myoung Soo Kima,
Volume 86, Issue 3, Pages (September 2014)
Presentation transcript:

Introduction: Eighth Banff Conference on Allograft Pathology - Edmonton, AB Kim Solez, M.D. and Lorraine C. Racusen

Slide 2 Making Banff into a verb! “Banff it” 2005 most important meeting yet. “Kicking the CAN” - Coming to grips with the morphologic counterparts of chronic graft failure - getting away from the nonspecificity of “CAN”. “Kicking the CAN” - Coming to grips with the morphologic counterparts of chronic graft failure - getting away from the nonspecificity of “CAN”. “Banff on a chip” - The emerging role of gene chip microarray results. “Banff on a chip” - The emerging role of gene chip microarray results. “Rules for the masses” - Revisiting clinical practice guidelines, C4d, new lesion scores. “Rules for the masses” - Revisiting clinical practice guidelines, C4d, new lesion scores.

Slide 3 Edmonton, where the Banff Meetings have been organized from since 1991! Largest metropolitan center between Toronto and Vancouver, and Canada's fifth-largest city. Largest metropolitan center between Toronto and Vancouver, and Canada's fifth-largest city. 2,263.7 hours of sunlight in the average year - more than any other major city in Canada. 2,263.7 hours of sunlight in the average year - more than any other major city in Canada. Average of 17 hours of daylight per day in June. Average of 17 hours of daylight per day in June. Edmonton’s River Valley is the largest stretch of urban parkland in North America with 7400 hectares; this vast parkland is approximately 12 times larger than Central Park in New York City Edmonton’s River Valley is the largest stretch of urban parkland in North America with 7400 hectares; this vast parkland is approximately 12 times larger than Central Park in New York City. Largest metropolitan center between Toronto and Vancouver, and Canada's fifth-largest city. Largest metropolitan center between Toronto and Vancouver, and Canada's fifth-largest city. 2,263.7 hours of sunlight in the average year - more than any other major city in Canada. 2,263.7 hours of sunlight in the average year - more than any other major city in Canada. Average of 17 hours of daylight per day in June. Average of 17 hours of daylight per day in June. Edmonton’s River Valley is the largest stretch of urban parkland in North America with 7400 hectares; this vast parkland is approximately 12 times larger than Central Park in New York City Edmonton’s River Valley is the largest stretch of urban parkland in North America with 7400 hectares; this vast parkland is approximately 12 times larger than Central Park in New York City.

Slide 4 The Banff Schema was first developed by a group of pathologists, nephrologists, and transplant surgeons at a meeting in Banff Canada August 2-4, The Banff Schema was first developed by a group of pathologists, nephrologists, and transplant surgeons at a meeting in Banff Canada August 2-4, The Banff Schema was first developed by a group of pathologists, nephrologists, and transplant surgeons at a meeting in Banff Canada August 2-4, The Banff Schema was first developed by a group of pathologists, nephrologists, and transplant surgeons at a meeting in Banff Canada August 2-4, It has continued to evolve through meetings every two years and has become the worldwide standard for interpretation of transplant biopsies. It has continued to evolve through meetings every two years and has become the worldwide standard for interpretation of transplant biopsies.

Slide 5 Banff Classification: Milestones 1991 First Conference 1991 First Conference 1993 First Kidney International publication 1993 First Kidney International publication 1995 Integration with CADI 1995 Integration with CADI 1997 Integration with CCTT classification 1997 Integration with CCTT classification 1999 Second KI paper. Clinical practice guidelines. Implantation biopsies, microwave Second KI paper. Clinical practice guidelines. Implantation biopsies, microwave Classification of antibody-mediated rejection 2001 Classification of antibody-mediated rejection Regulatory agencies participating Regulatory agencies participating 2003 Genomics focus, ptc cell accumulation scoring, macrophages Genomics focus, ptc cell accumulation scoring, macrophages.

Slide 6 Banff Classification - Subjects in Edmonton meeting July 15-21, 2005 Updates on Schemas for Diagnosis of Rejection Updates on Schemas for Diagnosis of Rejection Transcriptome Gene Chip Diagnoses Transcriptome Gene Chip Diagnoses Emerging Technologies Emerging Technologies Antibody-mediated rejection/C4d Antibody-mediated rejection/C4d Special Populations Special Populations Revisiting Clinical Practice Guidelines Revisiting Clinical Practice Guidelines Histologic hallmarks of sclerosing rejection: Strategies to establish diagnoses other than CAN. Histologic hallmarks of sclerosing rejection: Strategies to establish diagnoses other than CAN. Heart, lung, pancreas, and liver sessions in addition. Heart, lung, pancreas, and liver sessions in addition.

Slide 7 Much important work being presented in poster session! Poster session Monday, July 18th 5:30 - 7:30 5:30 - 7:30 Poster Viewing Session Poster Viewing Session Wine & Cheese Event Wine & Cheese Event Posters can be put up during the breaks or 7- 8 AM tomorrow or Monday Posters can be put up during the breaks or 7- 8 AM tomorrow or Monday

Slide 8 More than half of transplant biopsies in 2005 do not show rejection! Calcineurin inhibitor toxicity most common entity. Scoring/classification system must deal with all entities, not just rejection! New onset hyaline arteriolar thickening (ah) a sign of calcineurin inhibitor toxicity.

Slide 9

Slide 10 Non- Circumferential vs. Circumferential hyalinosis

Slide 11 Quantitative Criteria for Arteriolar Hyaline Thickening – Current scoring. 0 = No PAS-positive hyaline thickening 1 = Mild-to-moderate PAS-positive hyaline thickening in at least one arteriole 2 = Moderate-to-severe PAS-positive hyaline thickening in more than one arteriole 3 = Severe PAS-positive hyaline thickening in many arterioles

Slide 12 Quantitative Criteria for Arteriolar Hyaline Thickening – Proposed new scoring - Mihatsch 0 = No PAS-positive hyaline thickening 1 = PAS-positive hyaline thickening present in only one arteriole, no circular involvement 2 = PAS-positive hyaline thickening present in more than one arteriole, but no circular involvement 3 = PAS-positive hyaline thickening with circular involvement, independent of the number of arterioles involved

Slide 13 Quantitative Criteria for Arteriolar Hyaline Thickening – Study of Sis et al. (Banff ’05) The severity of ah scored by both criteria, was significantly correlated with serum creatinine at biopsy (p<0.05). Using Banff criteria, the mean rate of pairwise agreement was 57.8% with an overall kappa value of With the newly proposed criteria, the mean rate of pairwise agreement was 70% and the overall kappa value was The mean interslide variation rates using Banff criteria and the new criterion were 30.7% and 36.7%, respectively. The severity of ah scored by both criteria, was significantly correlated with serum creatinine at biopsy (p<0.05). Using Banff criteria, the mean rate of pairwise agreement was 57.8% with an overall kappa value of With the newly proposed criteria, the mean rate of pairwise agreement was 70% and the overall kappa value was The mean interslide variation rates using Banff criteria and the new criterion were 30.7% and 36.7%, respectively. Conclusion: While Banff and the recently proposed criteria for ah scoring resulted in fair to moderate interobserver agreement, the new criterion seems to be more objective and results in better interobserver reproducibility. There is a substantial variation in the distribution and severity of arteriolar lesions in an individual biopsy, therefore, evaluation of more than one section is crucial to determine the severity of arteriolar damage more accurately. Conclusion: While Banff and the recently proposed criteria for ah scoring resulted in fair to moderate interobserver agreement, the new criterion seems to be more objective and results in better interobserver reproducibility. There is a substantial variation in the distribution and severity of arteriolar lesions in an individual biopsy, therefore, evaluation of more than one section is crucial to determine the severity of arteriolar damage more accurately.

Slide 14

Slide 15 Intimal elastosis found to correlated with antibody mediated rejection! Sis, Hunter et al. Intimal elastosis - the deposition of elastic fibers in intima - significant association with class II antibodies in our study may suggest that antibody mediated injury could be one of the mechanisms leading to arterial injury and subsequent formation of neo-intima rich in elastic fibers. Intimal elastosis - the deposition of elastic fibers in intima - significant association with class II antibodies in our study may suggest that antibody mediated injury could be one of the mechanisms leading to arterial injury and subsequent formation of neo-intima rich in elastic fibers. 173 posttransplant biopsies from 127 patients with available anti-HLA Ab analysis Jan to March posttransplant biopsies from 127 patients with available anti-HLA Ab analysis Jan to March 2004

Slide 16 Moving from semiquantitative scoring to quantitative scoring by morphometry! Despite all the praise we have received for the Banff scoring system, a truly quantitative system would obviously be better if practical, so we are only half way there! Despite all the praise we have received for the Banff scoring system, a truly quantitative system would obviously be better if practical, so we are only half way there! Howie AJ: The Problems with BANFF, Transplantation 73:1383, 2002 “…other approaches should be tried such as morphometry” Howie AJ: The Problems with BANFF, Transplantation 73:1383, 2002 “…other approaches should be tried such as morphometry” Financially and technically impractical for most centers right now, but possibly doable in the near future. Financially and technically impractical for most centers right now, but possibly doable in the near future. Banff classification is based on semiquantitative assessment. Quantitative assessment would ultimately be better, just as the molecular biology/genomics alternative would be. But they must be made practical! Banff classification is based on semiquantitative assessment. Quantitative assessment would ultimately be better, just as the molecular biology/genomics alternative would be. But they must be made practical!

Slide 17 New Developments in Morphometry - Birk et al. (2005 Banff meeting) Used hue saturation intensity (HSI) image analysis software to quantify renal allograft interstitial fibrosis in pediatric protocol biopsies, significant correlation with Banff ci score and with decreased GFR and other clinical parameters. Used hue saturation intensity (HSI) image analysis software to quantify renal allograft interstitial fibrosis in pediatric protocol biopsies, significant correlation with Banff ci score and with decreased GFR and other clinical parameters.

Slide 18

Slide 19 Clinical practice guidelines, new lesion scoring etc. Revisiting 1999 guidelines. Revisiting 1999 guidelines. Methods review for C4d as a marker for antibody mediated rejection. Methods review for C4d as a marker for antibody mediated rejection. Peritubular capillary cell accumulation scoring. Peritubular capillary cell accumulation scoring.

Slide 20

Slide 21 Polys in peritubular capillaries in antibody-mediated rejection.

Slide Agreed upon clinical practice guidelines that need buy-in generally Implantation biopsies Implantation biopsies Rapid paraffin (microwave) processing for rapid reading rather than frozen sections Rapid paraffin (microwave) processing for rapid reading rather than frozen sections Routine (“protocol”) biopsies Routine (“protocol”) biopsies H&E, PAS (+/o silver), and trichrome or Sirius red stains H&E, PAS (+/o silver), and trichrome or Sirius red stains

Schedule of the Meeting Saturday, 16 July :00 - 8:20 Welcome, Opening Remarks - Kim Solez and Lorraine Racusen Plenary session 8:20 - 9:20 Keynote Address: Future directions in organ replacement. - Jeffrey Platt Transcriptome Gene Chip Moderator: Philip F. Halloran 9:20-11:50 12:00 - 1:00Lunch (Wedgwood Room)Lunch (Empire Terrace) PMEmpire Ballroom 12:00 - 1:00Lunch (Wedgwood Room)Lunch (Empire Terrace) PMEmpire Ballroom 1:00 - 1:30Experimental heart transplantation. - Thomas Mueller Emerging Technologies Moderator: Philip F. Halloran 1:30-4:30 Saturday, 16 July :00 - 8:20 Welcome, Opening Remarks - Kim Solez and Lorraine Racusen Plenary session 8:20 - 9:20 Keynote Address: Future directions in organ replacement. - Jeffrey Platt Transcriptome Gene Chip Moderator: Philip F. Halloran 9:20-11:50 12:00 - 1:00Lunch (Wedgwood Room)Lunch (Empire Terrace) PMEmpire Ballroom 12:00 - 1:00Lunch (Wedgwood Room)Lunch (Empire Terrace) PMEmpire Ballroom 1:00 - 1:30Experimental heart transplantation. - Thomas Mueller Emerging Technologies Moderator: Philip F. Halloran 1:30-4:30